Novo Nordisk is unveiling a subscription model for self-pay customers of its popular GLP-1 weight loss drug Wegovy with much lower prices for both the injectable and the pill through three telehealth services. It's the latest effort by drug makers to reduce prices which includes partnering with big box stores to entice more patients. NBC's Anne Thompson reports for TODAY.

March 31, 2026 Popular Weight-Loss Drug Wegovy Unveils Subscription Service Novo Nordisk is unveiling a subscription model for self-pay customers of its popular GLP-1 weight loss drug Wegovy with much lower prices for both the injectable and the pill through three telehealth services. It's the latest effort by drug makers to reduce prices which includes partnering with big box stores to entice more patients. NBC's Anne Thompson reports for TODAY. READ MORE Noah Wyle to Receive a Star on the Hollywood Walk of Fame WATCH NOW Céline Dion Announces Long-Awaited Return to the Stage WATCH NOW Longest-Serving United Airlines Female Pilot Celebrates Milestone WATCH NOW Saw it on TODAY 3RD HOUR OF TODAY Mikaela Shiffrin Talks 2026 Olympics, Winning 6th World Cup Title WATCH NOW TODAY WITH JENNA & SHEINELLE Alix Earle on Why She's 'A Little Scared' About New Reality Series WATCH NOW SHOP TODAY Spring Is Here! Shop Expert Picks To Get Outdoors, From $10 SHOP NOW Send us Feedback Follow us on Facebook More TODAY Newsletters Copyright © 2026 TODAY | 30 Rockefeller Plaza, New York, NY 10112 View in Browser | Manage Subscriptions | Unsubscribe | Privacy